Mechanical dispersion as a marker of left ventricular dysfunction and prognosis in stable coronary artery disease
Brede Kvisvik1,2,3, Erika Nerdrum Aagaard1,2, Lars Mørkrid4
1Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.
Insights
Mechanical dispersion (MD) shows promise as a marker for left ventricular (LV) dysfunction and poor prognosis in stable coronary artery disease (CAD). Increased MD is linked to adverse outcomes, offering value beyond ejection fraction (EF) and global longitudinal strain (GLS).
Area of Science:
- Cardiology
- Echocardiography
- Biomarkers
Background:
- Global longitudinal strain (GLS) is superior to ejection fraction (EF) for evaluating left ventricular (LV) function in stable coronary artery disease (CAD).
- The prognostic role of mechanical dispersion (MD) in stable CAD requires further investigation.
Purpose of the Study:
- To assess the potential of mechanical dispersion (MD) as a marker of LV dysfunction and long-term prognosis in patients with stable CAD.
- To compare the prognostic value of MD with EF and GLS in this patient cohort.
Main Methods:
- 160 patients with stable CAD underwent assessment of EF, GLS, and MD one year post-revascularization.
- Serum levels of high-sensitivity cardiac troponin I (hs-cTnI) and NT-proBNP were measured.
- Primary endpoint: all-cause mortality. Secondary endpoint: composite of mortality and major adverse cardiovascular events.
Main Results:
- Both GLS and MD correlated positively with hs-cTnI and NT-proBNP levels.
- Increased MD was observed in non-survivors and provided incremental prognostic value when added to EF and GLS.
- NT-proBNP outperformed echocardiographic markers in predicting adverse outcomes.
Conclusions:
- Mechanical dispersion (MD) may serve as a valuable marker for LV dysfunction and adverse prognosis in stable CAD patients.
- MD offers incremental prognostic information beyond traditional measures like EF and GLS.
- Further research is warranted to fully elucidate the role of MD in cardiovascular risk stratification.
Abstract:
Assessment of global longitudinal strain (GLS) is superior to ejection fraction (EF) in the evaluation of left ventricular (LV) function in patients with stable coronary artery disease (CAD). However, the role of mechanical dispersion (MD) in this context remains unresolved. We aimed to evaluate the potential role of MD as a marker of LV dysfunction and long-term prognosis in stable CAD. EF, GLS and MD were assessed in 160 patients with stable CAD, 1 year after successful coronary revascularization. Serum levels of high-sensitivity cardiac troponin I (hs-cTnI) and amino-terminal pro B-type natriuretic peptide (NT-proBNP) were quantified as surrogate markers of LV dysfunction. The primary endpoint was defined as all-cause mortality, the secondary endpoint was defined as the composite of all-cause mortality and hospitalization for acute myocardial infarction or heart failure during follow-up. Whereas no associations between EF and the biochemical markers of LV function were found, both GLS and MD correlated positively with increasing levels of hs-cTnI (R = 0.315, P < 0.001 and R = 0.442, P < 0.001, respectively) and NT-proBNP (R = 0.195, P = 0.016 and R = 0.390, P < 0.001, respectively). Median MD was 46 ms (interquartile range [IQR] 37-53) and was successfully quantified in 96% of the patients. During a median follow-up of 8.4 (IQR 8.2-8.8) years, 14 deaths and 29 secondary events occurred. MD was significantly increased in non-survivors, and provided incremental prognostic value when added to EF and GLS. NT-proBNP was superior to the echocardiographic markers in predicting adverse outcomes. MD may be a promising marker of LV dysfunction and adverse prognosis in stable CAD.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease I: Introduction


